Preclinical anti-cancer activity and multiple mechanisms of action of a cationic silver complex bearing N-heterocyclic carbene ligands
AuthorAllison, Simon J.
Cooper, Patricia A.
Shnyder, Steven D.
Wheelhouse, Richard T.
Phillips, Roger M.
KeywordSilver-N-heterocyclic carbene; Thioredoxin reductase inhibitor; Topoisomerase inhibitor; PARP1 inhibitor; Glycolytic inhibitor
Rights© 2017 Elsevier. Reproduced in accordance with the publisher's self-archiving policy. This manuscript version is made available under the CC-BY-NC-ND 4.0 license.